CSBR:NASDAQ
Champions Oncology Inc
4,68 USD
arrow_downward
-0,53%(-0,025) 1D
16-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,68 USD
High
4,68 USD
Low
4,68 USD
Mkt. cap
65,07 млн
Avg. vol.
8,15 миң
Volume
644,00
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,68 USD
High
4,68 USD
Low
4,68 USD
Mkt. cap
65,07 млн
Avg. vol.
8,15 миң
Volume
644,00
52-wk high
8,31 USD
52-wk low
4,52 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
Investing.com
·
21 мүнөт мурун
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 саат мурун
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
46 мүнөт мурун
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
1 саат мурун
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com